Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
about
Facing Hymenoptera Venom Allergy: From Natural to Recombinant AllergensDevelopment and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patientsCloning, expression, and analysis of a cDNA coding for the Dermatophagoides farinae group 21 (Der f 21) allergen.Mosquito salivary allergen Aed a 3: cloning, comprehensive molecular analysis, and clinical evaluation.Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B InfectionProgress in the development of specific immunotherapies for house dust mite allergies.Modified allergens and their potential to treat allergic disease.Advances in allergen immunotherapy: aiming for complete tolerance to allergens.Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study.Current developments for improving efficacy of allergy vaccines.Control Process for Manufacturing and Standardization of Allergenic Molecules.The efficiency of peptide immunotherapy for respiratory allergy.Allergen extracts and recombinant proteins: comparison of efficiency of in vitro allergy diagnostics using multiplex assay on a biological microchip.Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.Allergen Valency, Dose, and FcεRI Occupancy Set Thresholds for Secretory Responses to Pen a 1 and Motivate Design of Hypoallergens.Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model.A roadmap towards personalized immunology.Conformational IgE Epitope Mapping of Der p 2 and the Evaluations of Two Candidate Hypoallergens for Immunotherapy.Immunological Mechanisms in Allergic Diseases and Allergen Tolerance: The Role of Treg Cells.Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases.
P2860
Q26799910-EA6B3DA3-14D0-4104-A2E8-31EF39CC11CCQ27700098-37EC2882-6B1F-4E31-9306-7645ACDCC701Q34978803-694A51D7-AC17-4C67-ACD5-E9B036304449Q35853310-B501F5CD-BFCA-4C63-BDEB-3A8830653F30Q37309327-A65164C8-4E5B-4861-BF0C-5FABBC018D68Q38245974-8DA254C8-A8D1-48F4-B2F8-E2EBF0A004EAQ38255585-A76B02F0-D7E1-49EC-AE97-F930B0EC8E31Q38391526-B58AA213-1E77-4AD0-87D7-B1763968C49CQ38396322-1EC4854B-1645-45C5-ABB3-3D017C81E0A7Q38503330-09D518CB-9B16-4A29-8535-622433BF1EAAQ38542843-149C06B4-F2E5-42F0-A9DD-11D2FA2B905EQ38744223-D90203D3-0783-49F8-AD51-B9E54D2F7F41Q38959808-F6617382-DA56-441D-8F83-5A434C3413B4Q46651312-F34DCAB3-CDB3-4699-96BD-8D6ADFB76DB0Q48026126-614096DF-DACF-49A6-B6B9-FFE8B1BB3CB2Q48273752-B952388E-8BEF-411B-8362-3E99BCD571F7Q50104991-6A99F2A2-ABFF-413B-B320-00BC10FC3F60Q50358296-FFCC9BBC-F615-4BE1-BEB0-75D200D5E1EFQ55669682-CF729498-DE49-42FF-AF49-7A857A3E8097Q55693712-3F67E967-09F9-4322-A7CD-A9F171D3D361
P2860
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Allergen Peptides, Recombinant ...... llergen-Specific Immunotherapy
@ast
Allergen Peptides, Recombinant ...... llergen-Specific Immunotherapy
@en
Allergen Peptides, Recombinant ...... llergen-Specific Immunotherapy
@nl
type
label
Allergen Peptides, Recombinant ...... llergen-Specific Immunotherapy
@ast
Allergen Peptides, Recombinant ...... llergen-Specific Immunotherapy
@en
Allergen Peptides, Recombinant ...... llergen-Specific Immunotherapy
@nl
prefLabel
Allergen Peptides, Recombinant ...... llergen-Specific Immunotherapy
@ast
Allergen Peptides, Recombinant ...... llergen-Specific Immunotherapy
@en
Allergen Peptides, Recombinant ...... llergen-Specific Immunotherapy
@nl
P2093
P2860
P3181
P1476
Allergen Peptides, Recombinant ...... llergen-Specific Immunotherapy
@en
P2093
Christian Lupinek
Katharina Marth
Margarete Focke-Tejkl
Verena Niederberger
P2860
P2888
P304
P3181
P356
10.1007/S40521-013-0006-5
P577
2014-01-01T00:00:00Z
P5875
P6179
1041686191